Katalog Plus
Bibliothek der Frankfurt UAS
Bald neuer Katalog: sichern Sie sich schon vorab Ihre persönlichen Merklisten im Nutzerkonto: Anleitung.
Dieses Ergebnis aus BASE kann Gästen nicht angezeigt werden.  Login für vollen Zugriff.

CytoSorb hemoadsorption in rhabdomyolysis-induced acute kidney injury: a case report from a tertiary hospital in Bangladesh

Title: CytoSorb hemoadsorption in rhabdomyolysis-induced acute kidney injury: a case report from a tertiary hospital in Bangladesh
Authors: Alam, Mohammad J.; Azad, Showkat; Hossain, M. Z. M.; Ahmed, Faisal; Chowdhury, Nasreen; Russel, Sarwar K.; Rahman, Salman; Islam, M. Shahidul; Saihum, Asif; Billah, Masum; Barua, Shantanu; Hossen, Muhammad I.; Anisa Anan; Emu, Showrov S.; Das, Raju; Saleh, Adnan B.; Shukkur, Mohammed I.; Bhuiyan, Mohammad S.; Rahman, Muhammad M.; Dutta, Diponkar; Hussein M. Nizamuddin; Haque, Tausiful; Noor, Nargis I.; Nath, Avijith K.; Zafar, Tasnia; Rakshit, Sudip; Siam, M. Imran S.; Tasnim, Jarin
Source: International Journal of Research in Medical Sciences; Vol. 13 No. 11 (2025): November 2025; 4933-4936 ; 2320-6012 ; 2320-6071
Publisher Information: Medip Academy
Publication Year: 2025
Subject Terms: Rhabdomyolysis; CytoSorb; Acute kidney injury; Hemoadsorption; Creatine phosphokinase
Description: Rhabdomyolysis is a serious clinical condition involving the breakdown of skeletal muscle, leading to the release of intracellular components into circulation. Among its complications, acute kidney injury (AKI) is the most critical, occurring in up to 50% of cases. This report presents the case of a 42-year-old male with schizophrenia and hypertension who developed rhabdomyolysis-induced AKI following a fall. He exhibited markedly elevated creatine phosphokinase (CPK) levels (360,000 u/l) and deteriorating renal function. In addition to supportive management, CytoSorb hemoadsorption was initiated. Over three sessions, CPK levels dropped to 174 u/l, and serum creatinine declined from 3.53 mg/dl to 2.16 mg/dl. This case demonstrates that CytoSorb therapy can be effective even in limited-resource settings where myoglobin assays are unavailable, offering a promising strategy for early intervention in rhabdomyolysis-induced AKI. Our experience suggests early initiation of hemoadsorption could serve as an effective adjunct in managing challenging cases where conventional therapies alone may be insufficient.
Document Type: article in journal/newspaper
File Description: application/pdf
Language: English
Relation: https://www.msjonline.org/index.php/ijrms/article/view/15643/10049; https://www.msjonline.org/index.php/ijrms/article/view/15643
DOI: 10.18203/2320-6012.ijrms20253624
Availability: https://www.msjonline.org/index.php/ijrms/article/view/15643; https://doi.org/10.18203/2320-6012.ijrms20253624
Rights: Copyright (c) 2025 International Journal of Research in Medical Sciences
Accession Number: edsbas.C1818B95
Database: BASE